YSE Beauty, Founded by Molly Sims, Closes $15M Series A to Accelerate Sephora and E-commerce Growth

YSE Beauty, the clinically tested skincare brand founded by entrepreneur Molly Sims, has announced the successful close of a $15 million Series A growth equity investment. The substantial capital infusion will be used to fuel the brand’s accelerating momentum, including forthcoming expansion across all Sephora doors in the US and continued exponential growth in its…

Read More

Hi-Dolphin COFE+: Pioneering the Future of Coffee with Innovation and Global Impact

In a groundbreaking achievement for Shanghai’s technological landscape, Hi-Dolphin COFE+ has once again made headlines by swiftly securing its Series A second round of financing within a single week. This feat, spearheaded by an esteemed family fund, underscores not only the company’s meteoric rise but also the resounding confidence of investors in its disruptive vision….

Read More

CustoMED Secures $6M to Put AI-Powered, Surgeon-First Orthopedic Surgery on the Global Map

Israeli medtech startup CustoMED has closed a $6 million funding round aimed at scaling its AI-driven, 3D-printed solutions for patient-specific orthopedic surgery. The round brought together strategic investors including Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority, a leading orthopedic implant company, and Avishai Abrahami, co-founder and CEO of Wix. CustoMED’s platform…

Read More

Clarity Pediatrics Raises $14.5 Million Series A to Expand Virtual Chronic Care into Pediatric Obesity

Clarity Pediatrics, a rapidly growing telehealth company focused on pediatric chronic care, has secured $14.5 million in Series A funding, marking a significant step in its mission to modernize specialty care for children and families. The round was led by Jackson Square Ventures and included new investors City Light Capital, MassMutual Catalyst Fund II, GingerBread…

Read More

PayPal Ventures Expands Investment in Chaos Labs, Reinforcing Confidence in Onchain Risk Management

PayPal Ventures, the global venture capital arm of PayPal, has announced a significant additional investment in Chaos Labs, an emerging leader in onchain risk management. This move not only highlights PayPal’s faith in Chaos Labs’ innovative blockchain solutions but also underscores the growing importance of risk management in the rapidly evolving crypto landscape. Chaos Labs…

Read More

Revolv Empowers California Corporations with Significant EV Infrastructure Grant from CALSTART’s EnergIIZE Program

Revolv, a prominent provider in electric commercial fleets, has announced securing a significant funding milestone through CALSTART’s EnergIIZE program. The initiative aims to accelerate the transition of California corporations from combustion to electric fleets by covering 70% of the total charging infrastructure costs. This latest grant underscores Revolv’s pivotal role in facilitating access to critical…

Read More

SoSoValue Secures $4.15 Million Seed Funding to Revolutionize AI-Driven Crypto Investment Research

Singapore-based fintech startup SoSoValue has announced the successful closure of a $4.15 million seed funding round, led by prominent investors including HongShan, GSR Markets, Alumni Ventures, CoinSummer Labs, and One Piece Labs. Noteworthy contributions also came from co-founders of leading Web3 and AI technology firms, alongside early backers of Ethereum and Gitcoin. Founded with a…

Read More

Journify Secures $4 Million to Pioneer AI-Driven, Privacy-Centric Marketing Future

In a bold stride toward reshaping the global marketing landscape, Journify has clinched a $4 million funding round, igniting excitement across the tech and business worlds. Announced today, this investment, spearheaded by the renowned venture capital powerhouse Silicon Badia and bolstered by RZM alongside other key players, marks a pivotal moment for the innovative firm….

Read More

PolTREG Reports Long-Term Success in Type-1 Diabetes Treatment Study

PolTREG S.A., a pioneering biotechnology firm specializing in cellular therapies for autoimmune disorders, has announced groundbreaking findings from its long-term clinical study on PTG-007, a polyclonal Treg cell therapy for early-onset type-1 diabetes (T1D). Over a span of 7 to 12 years, pediatric patients treated with PTG-007 demonstrated sustained insulin secretion, contrasting starkly with a…

Read More

PatientPartner Secures $7M in Seed Funding to Transform Patient Engagement

PatientPartner, an innovative health-tech startup dedicated to advancing patient engagement, has successfully raised $7 million in its latest Seed Round of funding. This significant investment, spearheaded by LionBird and FCA Venture Partners, includes $3.5 million in new capital and $3.5 million in convertible debt from Alethea Capital and additional strategic investors. Founded by Forbes Under…

Read More